United States News Todas as matérias

Figure Technology Solutions (NASDAQ:FIGR) announced a definitive agreement to acquire Kiavi, an AI-powered lending platform tailored for residential real estate investors, in a transaction valued at $717 million.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported a net profit for the first quarter of fiscal year 2026, driven primarily by a substantial, non-cash accounting gain linked to its recent acquisition of Recipharm Israel.

Cullinan Therapeutics (NASDAQ:CGEM) reported encouraging initial clinical data and outlined expanded development pathways for its portfolio of dual-targeting T-cell engagers, marking an expansion for the oncology-focused biotech into the autoimmune space.

Artelo Biosciences (NASDAQ:ARTL) announced encouraging human metabolite identification and profiling data for its lead drug candidate, ART26.12, as the biotechnology company aims to de-risk the development of its novel non-opioid pain therapy.

Organon (NYSE:OGN) announced that the US Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Tofidence, expanding the therapeutic indications of the drug within the competitive US biosimilars market.

Core & Main (NYSE:CNM) reported improved financial results for the first quarter of fiscal year 2026, supported by reliable infrastructure demand and active cost navigation in an otherwise mixed industrial environment.

Nvni Group (NASDAQ:NVNI) announced substantial progress toward completing its acquisition of a 51% controlling interest in the holding company operating Beyondsoft Corporation’s consulting and services business across the United States, Brazil, and Singapore.

Tecnoglass (NYSE:TLGS) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.15 per share for the second quarter of 2026.

Harrow (NASDAQ:HROW) announced the formal commercial re-launch of Verkazia, a targeted prescription therapy for vernal keratoconjunctivitis (VKC), an underdiagnosed but severe chronic allergic eye disease that primarily affects children.

Chewy (NYSE:CHWY) delivered a strong financial performance for the first quarter of fiscal year 2026, characterized by robust top-line growth and a significant increase in profitability despite a dynamic broader consumer environment.

APA Corporation (NASDAQ:APA) announced an agreement to acquire Savant Alaska for approximately $70 million in upfront cash, moving to lock down strategic midstream and field infrastructure on Alaska's eastern North Slope.

Opera (NASDAQ:OPRA) announced that its Board of Directors has declared a semi-annual cash dividend of $0.40 per share for holders of its ordinary shares and American Depositary Shares (ADSs).

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $284.8 billion as of May 31, 2026.

J.Jill (NYSE:JILL) reported a 6% decline in net sales for the first quarter of fiscal 2026, falling to $144.4 million from $153.6 million in the year-ago period.

TE Connectivity (NYSE:TEL) announced Wednesday that its board of directors has declared a regular quarterly cash dividend of $0.78 per ordinary share.

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) posted record consolidated revenue for May 2026, setting a new single-month high as global technology enterprises continue to aggressively ramp up hardware procurement for artificial intelligence applications.

Yuanbao (NASDAQ:YB), a technology-driven online insurance distributor in China, reported a 31.4 percent surge in net income for the first quarter of 2026, driven by robust top-line momentum across its digital platform.

ChipMOS TECHNOLOGIES (NASDAQ:IMOS) reported a 17.7 percent year-over-year increase in its unaudited consolidated revenue for May 2026, capitalizing on an artificial intelligence sector expansion that continues to outpace broader manufacturing capacity.

Cango (NYSE:CANG) published its operational update for May 2026, detailing the capacity metrics of its global digital asset mining network as the company continues to transition toward an integrated energy and artificial intelligence computing platform.

Cheetah Mobile (NYSE:CMCM) reported a significantly narrowed net loss for the first quarter of 2026, capitalizing on an aggressive operational pivot that generated a triple-digit surge within its commercial robotics business alongside steady growth in cloud infrastructure.

Crude oil prices remained tightly range-bound on Wednesday morning as escalating military hostilities between the United States and Iran counterbalanced supportive domestic inventory data. Traders are weighing the structural threat of a prolonged Middle East chokepoint shutdown against slowing global demand signals.

Meta Platforms (NASDAQ:META) is partnering with Reliance Industries to build its first artificial intelligence data center in India, joining a massive wave of global technology capital flowing into the South Asian country’s computing infrastructure.

Eli Lilly (NYSE:LLY) secured U.S. regulatory approval for a less-frequent dosing regimen of its eczema treatment Ebglyss, providing patients with a maintenance option that significantly reduces the annual injection burden.

Rafael Holdings (NYSE:RFL) announced that the last patient has completed the final 96-week study visit in its pivotal Phase 3 TransportNPC™ trial evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C (NPC).